厄贝沙坦氢氯噻嗪治疗原发性高血压的临床疗效观察 罗桂艳(抚顺市中心医院辽宁抚顺 113006) 【中图分类号】【文献标识码】A【文章编号】1672-5085(2012)5-0083-02 【摘要】目的探讨厄贝沙坦氢氯噻嗪在治疗原发性高血压方面的临床疗效。方法随机将276例原发性高血压患者分为治疗组和对照组,治疗组138例患者给予厄贝沙坦氢氯噻嗪片治疗,对照组138例患者给予尼卡地平治疗。分析对比两组患者在治疗半年后的临床效果。结果治疗组的显效率、总有效率以及不良反应发生率与对照组相比均具有极显著性的差异(P<)。结论厄贝沙坦氢氯噻嗪可以有效的治疗原发性高血压,安全性较高,值得在临床上推广使用。 【关键词】厄贝沙坦氢氯噻嗪片尼卡地平原发性高血压 【Abstract】Objective:TO discuss the clinical effect of Irbesartan and Hydrochlorothiazide in treatment of primary :276 cases of primary hypertension patients were randomly divided into the treatment group and the control group,138 patients in the treatment group were treated with Irbesartan and Hydrochlorothiazide tablets,138 patients in the control group were treated with Nicardipine,Analysis pariso,the clinical effect of two groups after half a :The effective rate,the total effective rate and adverse reaction rate in the treatment group all have very significant differences from control group (P<). Conclusion:Irbesartan and Hydrochlorothiazide can effectively treat hypertension and has high security,it is mended to use in clinical practice. 【Key words】Irbesartan and Hydrochlorothiazide tablets Nicardipine primary hypertension 原发性高血压又称高血压病,是比较常见的心血管疾病,占高血压总患者的 95%以上[1],患者除了高血压本身有关的症状以外,长期高血压严重影响重要脏器如心、脑、肾的功能,最终导致器官的功能衰竭[2]。虽然目前医学对原发性高血压的研究有了很大的进步,相应的诊断或治疗方法也不断提高,但它迄今仍是心脑血管疾病死亡的主要原因之一[3]。因此必须提高对高血压病的
